If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.

Valneva has recieved Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first ...

Valneva (VALN) announced that the Medicines and Healthcare products Regulatory Agency or MHRA has granted marketing authorization in the United ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

A new virus related to the deadly Nipah and Hendra viruses has been detected in shrews in the U.S. However, scientists say ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

The systematic review found that resveratrol ... Zika Uses Human Skin as 'Mosquito Magnet' to Spread Virus Further Jan. 30, 2025 — Zika virus hijacks the skin of its human host to send out ...

Zika Uses Human Skin as 'Mosquito Magnet' to Spread Virus Further Jan. 30 ... Nov. 14, 2024 — Collecting images of suspicious-looking skin growths and sending them off-site for specialists ...